[Lipoilcarnosine: synthesis, study of physico-chemical and antioxidant properties, biological activity]. 2018

S L Stvolinsky, and N A Antonova, and O I Kulikova, and A V Lopachev, and D A Abaimov, and I Al-Baidani, and O M Lopacheva, and T N Fedorova, and A P Kaplun, and G M Sorokoumova
Research Center of Neurology, Moscow, Russia.

Synthesis of lipoilcarnosine (LipC) - a conjugated molecule based on two natural antioxidants, carnosine and a-lipoic acid, is described. Its physico-chemical, antioxidant properties and biological activity are characterized. According to reversed-phase HPLC with a UV detector, purity of the final product was 89.3%. The individuality of the obtained sodium salt of LipC was confirmed by tandem HPLC-mass spectrometry. High resistance of LipC to hydrolysis with serum carnosinase was demonstrated. The antioxidant activity of LipC measured by reaction with the formation of thiobarbituric acid reacting substances and kinetic parameters of iron-induced chemiluminescence was higher than that of carnosine and lipoic acid. LipC did not affect viability of SH-SY5Y human neuroblastoma culture cells, differentiated towards the dopaminergic type, at concentrations not exceeding 5 mM. At the concentration range of 0.1-0.25 mM LipC protected neuronal cells against 1-methyl-4-phenylpyridinium (MPP + )-induced toxicity.

UI MeSH Term Description Entries
D002336 Carnosine A naturally occurring dipeptide neuropeptide found in muscles. Carnosine Hydrochloride,Carnosine, (D-His)-Isomer,L-Carnosine,beta-Alanylhistidine,Hydrochloride, Carnosine,L Carnosine,beta Alanylhistidine
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000975 Antioxidants Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. Anti-Oxidant,Antioxidant,Antioxidant Activity,Endogenous Antioxidant,Endogenous Antioxidants,Anti-Oxidant Effect,Anti-Oxidant Effects,Anti-Oxidants,Antioxidant Effect,Antioxidant Effects,Activity, Antioxidant,Anti Oxidant,Anti Oxidant Effect,Anti Oxidant Effects,Anti Oxidants,Antioxidant, Endogenous,Antioxidants, Endogenous
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D020267 MPTP Poisoning A condition caused by the neurotoxin MPTP which causes selective destruction of nigrostriatal dopaminergic neurons. Clinical features include irreversible parkinsonian signs including rigidity and bradykinesia (PARKINSON DISEASE, SECONDARY). MPTP toxicity is also used as an animal model for the study of PARKINSON DISEASE. (Adams et al., Principles of Neurology, 6th ed, p1072; Neurology 1986 Feb;36(2):250-8) MPTP Neurotoxicity Syndrome,MPTP-Induced Degeneration of the Striatum,MPTP-Induced Parkinsonism,Neurotoxicity Syndrome, MPTP,Poisoning, 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine,MPTP Induced Degeneration of the Striatum,MPTP Induced Parkinsonism,MPTP Neurotoxicity Syndromes,Neurotoxicity Syndromes, MPTP,Parkinsonism, MPTP-Induced,Poisoning, MPTP

Related Publications

S L Stvolinsky, and N A Antonova, and O I Kulikova, and A V Lopachev, and D A Abaimov, and I Al-Baidani, and O M Lopacheva, and T N Fedorova, and A P Kaplun, and G M Sorokoumova
January 1978, Prikladnaia biokhimiia i mikrobiologiia,
S L Stvolinsky, and N A Antonova, and O I Kulikova, and A V Lopachev, and D A Abaimov, and I Al-Baidani, and O M Lopacheva, and T N Fedorova, and A P Kaplun, and G M Sorokoumova
March 1998, Artificial cells, blood substitutes, and immobilization biotechnology,
S L Stvolinsky, and N A Antonova, and O I Kulikova, and A V Lopachev, and D A Abaimov, and I Al-Baidani, and O M Lopacheva, and T N Fedorova, and A P Kaplun, and G M Sorokoumova
January 1988, Postepy higieny i medycyny doswiadczalnej,
S L Stvolinsky, and N A Antonova, and O I Kulikova, and A V Lopachev, and D A Abaimov, and I Al-Baidani, and O M Lopacheva, and T N Fedorova, and A P Kaplun, and G M Sorokoumova
July 1978, Polski tygodnik lekarski (Warsaw, Poland : 1960),
S L Stvolinsky, and N A Antonova, and O I Kulikova, and A V Lopachev, and D A Abaimov, and I Al-Baidani, and O M Lopacheva, and T N Fedorova, and A P Kaplun, and G M Sorokoumova
June 1988, Gigiena truda i professional'nye zabolevaniia,
S L Stvolinsky, and N A Antonova, and O I Kulikova, and A V Lopachev, and D A Abaimov, and I Al-Baidani, and O M Lopacheva, and T N Fedorova, and A P Kaplun, and G M Sorokoumova
January 1971, Postepy higieny i medycyny doswiadczalnej,
S L Stvolinsky, and N A Antonova, and O I Kulikova, and A V Lopachev, and D A Abaimov, and I Al-Baidani, and O M Lopacheva, and T N Fedorova, and A P Kaplun, and G M Sorokoumova
January 1971, Annali Sclavo; rivista di microbiologia e di immunologia,
S L Stvolinsky, and N A Antonova, and O I Kulikova, and A V Lopachev, and D A Abaimov, and I Al-Baidani, and O M Lopacheva, and T N Fedorova, and A P Kaplun, and G M Sorokoumova
April 1986, The Journal of antibiotics,
S L Stvolinsky, and N A Antonova, and O I Kulikova, and A V Lopachev, and D A Abaimov, and I Al-Baidani, and O M Lopacheva, and T N Fedorova, and A P Kaplun, and G M Sorokoumova
July 2021, Nanomaterials (Basel, Switzerland),
S L Stvolinsky, and N A Antonova, and O I Kulikova, and A V Lopachev, and D A Abaimov, and I Al-Baidani, and O M Lopacheva, and T N Fedorova, and A P Kaplun, and G M Sorokoumova
November 2020, Molecules (Basel, Switzerland),
Copied contents to your clipboard!